These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28275913)

  • 1. Sigma-1 Receptor and Pain.
    Merlos M; Romero L; Zamanillo D; Plata-Salamán C; Vela JM
    Handb Exp Pharmacol; 2017; 244():131-161. PubMed ID: 28275913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Modulation of the Sigma 1 Receptor and the Treatment of Pain.
    Merlos M; Burgueño J; Portillo-Salido E; Plata-Salamán CR; Vela JM
    Adv Exp Med Biol; 2017; 964():85-107. PubMed ID: 28315267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociception by Sigma-1 Receptor Antagonists: Central and Peripheral Effects.
    Romero L; Merlos M; Vela JM
    Adv Pharmacol; 2016; 75():179-215. PubMed ID: 26920013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigational sigma-1 receptor antagonists for the treatment of pain.
    Vela JM; Merlos M; Almansa C
    Expert Opin Investig Drugs; 2015; 24(7):883-96. PubMed ID: 26037209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective sigma-1 receptor antagonists for the treatment of pain.
    Almansa C; Vela JM
    Future Med Chem; 2014 Jun; 6(10):1179-99. PubMed ID: 25078137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S1RA, a selective sigma-1 receptor antagonist, inhibits inflammatory pain in the carrageenan and complete Freund's adjuvant models in mice.
    Gris G; Merlos M; Vela JM; Zamanillo D; Portillo-Salido E
    Behav Pharmacol; 2014 Jun; 25(3):226-35. PubMed ID: 24776490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception.
    Sánchez-Blázquez P; Cortés-Montero E; Rodríguez-Muñoz M; Merlos M; Garzón-Niño J
    Mol Brain; 2020 Nov; 13(1):150. PubMed ID: 33176836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sigma-1 Receptor Antagonists: A New Class of Neuromodulatory Analgesics.
    Sánchez-Fernández C; Entrena JM; Baeyens JM; Cobos EJ
    Adv Exp Med Biol; 2017; 964():109-132. PubMed ID: 28315268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice.
    Castany S; Gris G; Vela JM; Verdú E; Boadas-Vaello P
    Sci Rep; 2018 Mar; 8(1):3873. PubMed ID: 29497125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sigma 1 receptor: a new therapeutic target for pain.
    Zamanillo D; Romero L; Merlos M; Vela JM
    Eur J Pharmacol; 2013 Sep; 716(1-3):78-93. PubMed ID: 23500210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective sigma-1 receptor antagonist E-52862 attenuates neuropathic pain of different aetiology in rats.
    Gris G; Portillo-Salido E; Aubel B; Darbaky Y; Deseure K; Vela JM; Merlos M; Zamanillo D
    Sci Rep; 2016 Apr; 6():24591. PubMed ID: 27087602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sigma-1 receptor activity in primary sensory neurons is a critical driver of neuropathic pain.
    Shin SM; Wang F; Qiu C; Itson-Zoske B; Hogan QH; Yu H
    Gene Ther; 2022 Feb; 29(1-2):1-15. PubMed ID: 32424233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice.
    Nieto FR; Cendán CM; Cañizares FJ; Cubero MA; Vela JM; Fernández-Segura E; Baeyens JM
    Mol Pain; 2014 Feb; 10():11. PubMed ID: 24517272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive effect of LMH-2, a new sigma-1 receptor antagonist analog of haloperidol, on the neuropathic pain of diabetic mice.
    Ventura-Martínez R; Ángeles-López GE; González-Ugalde D; Domínguez-Páez T; Navarrete-Vázquez G; Jaimez R; Déciga-Campos M
    Biomed Pharmacother; 2024 May; 174():116524. PubMed ID: 38574622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of N‑(benzylpiperidinyl)‑4‑fluorobenzamide: A haloperidol analog that reduces neuropathic nociception via σ
    Déciga-Campos M; Melo-Hernández LA; Torres-Gómez H; Wünsch B; Schepmann D; González-Trujano ME; Espinosa-Juárez J; López-Muñoz FJ; Navarrete-Vázquez G
    Life Sci; 2020 Mar; 245():117348. PubMed ID: 31981633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice.
    Sahn JJ; Mejia GL; Ray PR; Martin SF; Price TJ
    ACS Chem Neurosci; 2017 Aug; 8(8):1801-1811. PubMed ID: 28644012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control.
    Rodríguez-Muñoz M; Sánchez-Blázquez P; Herrero-Labrador R; Martínez-Murillo R; Merlos M; Vela JM; Garzón J
    Antioxid Redox Signal; 2015 Apr; 22(10):799-818. PubMed ID: 25557043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization.
    Romero L; Zamanillo D; Nadal X; Sánchez-Arroyos R; Rivera-Arconada I; Dordal A; Montero A; Muro A; Bura A; Segalés C; Laloya M; Hernández E; Portillo-Salido E; Escriche M; Codony X; Encina G; Burgueño J; Merlos M; Baeyens JM; Giraldo J; López-García JA; Maldonado R; Plata-Salamán CR; Vela JM
    Br J Pharmacol; 2012 Aug; 166(8):2289-306. PubMed ID: 22404321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supraspinal and Peripheral, but Not Intrathecal, σ
    Vidal-Torres A; Fernández-Pastor B; Carceller A; Vela JM; Merlos M; Zamanillo D
    Front Pharmacol; 2019; 10():422. PubMed ID: 31068818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer Liabilities of Use.
    Wilson LL; Eans SO; Ramadan-Siraj I; Modica MN; Romeo G; Intagliata S; McLaughlin JP
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.